Halozyme Therapeutics (HALO) Short term Debt (2013 - 2026)
Halozyme Therapeutics (HALO) posted quarterly Short term Debt of $208.7 million for Q1 2026, down 70.63% quarter-over-quarter from $710.7 million in Q3 2025.
Halozyme Therapeutics (HALO) Short term Debt (2013 - 2026) Analysis & Trends
Halozyme Therapeutics (HALO) has reported Short term Debt for 12 consecutive years, with $208.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Short term Debt changed N/A year-over-year to $208.7 million; the TTM figure through Mar 2026 stood at $208.7 million (changed N/A YoY), while the FY2022 annual figure was $13.3 million, down 85.09% from the prior year.
- Short term Debt declined to $208.7 million in Q1 2026 per HALO's latest filing, from $710.7 million in the prior quarter.
- Across five years, Short term Debt topped out at $710.7 million in Q3 2025 and bottomed at $13.3 million in Q3 2022.
- Historically, Short term Debt has averaged $189.1 million across 3 years, with a median of $94.3 million in 2022.
- On a YoY basis, Short term Debt climbed as much as 11.08% in 2022 and fell as far as 85.09% in 2022.
- Halozyme Therapeutics' Short term Debt stood at $13.3 million in 2022, then surged by 5229.87% to $710.7 million in 2025, then tumbled by 70.63% to $208.7 million in 2026.
- Business Quant data shows HALO's Short term Debt at $208.7 million in Q1 2026, $710.7 million in Q3 2025, and $13.3 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Halozyme Therapeutics | 11.25 Bn | 11.02 Bn | 401.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 208.97 Mn |
| Mar 31, 2026 | 208.74 Mn |
| Sep 30, 2025 | 710.69 Mn |
| Dec 31, 2022 | 13.33 Mn |
| Sep 30, 2022 | 13.32 Mn |
| Jun 30, 2022 | 99.05 Mn |
| Mar 31, 2022 | 89.55 Mn |
| Dec 31, 2021 | 89.42 Mn |
| Sep 30, 2021 | 89.25 Mn |
| Jun 30, 2021 | 89.17 Mn |
| Mar 31, 2021 | 89.04 Mn |
| Dec 31, 2020 | 397.23 Mn |
| Mar 31, 2020 | 2.86 Mn |
| Dec 31, 2019 | 19.54 Mn |
| Sep 30, 2019 | 54.54 Mn |
| Jun 30, 2019 | 70.88 Mn |
| Mar 31, 2019 | 86.66 Mn |
| Dec 31, 2018 | 91.51 Mn |
| Sep 30, 2018 | 88.52 Mn |
| Jun 30, 2018 | 86.97 Mn |